Russian Federation vs Rwanda: Average cost of tuberculosis treatment by type
Russian Federation
20 constant 2022 US$
in 2024
Rwanda
20 constant 2022 US$
in 2024
Russian Federation rank
26th
Rwanda rank
26th
Average cost of tuberculosis treatment by type over time
- Russian Federation
- Rwanda
How they compare
Russian Federation currently reports 20 constant 2022 US$ against 20 constant 2022 US$ in Rwanda, a difference of 0 constant 2022 US$.
The two have swapped places 1 time across 5 shared years of data; in 2019 it was Russian Federation ahead.
Russian Federation ranks 26th and Rwanda ranks 26th of 62 countries.
Russian Federation has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Russian Federation | Rwanda | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 17 constant 2022 US$ | 13 constant 2022 US$ | 4 constant 2022 US$ | Russian Federation |
| 2020s | 18 constant 2022 US$ | 17.25 constant 2022 US$ | 0.75 constant 2022 US$ | Russian Federation |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of tuberculosis treatment by type, Russian Federation or Rwanda?
- Russian Federation, at 20 constant 2022 US$ against 20 constant 2022 US$ in Rwanda as of 2024.
- What is the difference in average cost of tuberculosis treatment by type between Russian Federation and Rwanda?
- 0 constant 2022 US$, with Russian Federation ahead.
- How many years of comparable data are there for Russian Federation and Rwanda?
- 5 years are reported by both, from 2019 to 2024.
- How do Russian Federation and Rwanda rank globally for average cost of tuberculosis treatment by type?
- Russian Federation ranks 26th and Rwanda ranks 26th of 62 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of tuberculosis treatment by type. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per person starting tuberculosis preventive treatment, excluding buffer stock.